Literature DB >> 9072543

Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis.

S Thamilselvan1, R L Hackett, S R Khan.   

Abstract

PURPOSE: To determine if lipid peroxidation plays a role in renal injury associated with experimental nephrolithiasis.
MATERIALS AND METHODS: Hyperoxaluria was produced in rats by ethylene glycol in drinking water. At 15, 30 and 60 days of treatment, urinary oxalate, lipid peroxide, calcium oxalate crystals, enzymes and tissue lipid peroxide were measured.
RESULTS: Urinary oxalate increased significantly at all time periods and was associated with crystalluria. Lipid peroxides in kidney tissue and urine increased at all time periods. Tissue calcium oxalate crystal deposits from 0 to 1+ were present on day 15, but present in all animals on days 30 and 60. Renal tubular cell damage was confirmed by an increase in urinary marker enzymes.
CONCLUSIONS: Renal cell damage is associated with lipid peroxide production indicating cell injury due to the production of free radicals. The damage appears due primarily to hyperoxaluria and is augmented by crystal deposition in the renal tubules.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9072543

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  53 in total

1.  Effects of vitamin E ingestion on plasma and urinary risk factors for calcium oxalate urolithiasis in two population groups having different stone-risk profiles: evidence of different physiological handling mechanisms.

Authors:  Takalani Theka; Allen Rodgers; Sonja Lewandowski; Dawn Webber; Shameez Allie-Hamdulay
Journal:  Urol Res       Date:  2011-12-03

2.  Urinary MCP-1、HMGB1 increased in calcium nephrolithiasis patients and the influence of hypercalciuria on the production of the two cytokines.

Authors:  Yang Wang; Chun Sun; Chengyang Li; Yaoliang Deng; Guohua Zeng; Zhiwei Tao; Xiang Wang; Xiaofeng Guan; Yutong Zhao
Journal:  Urolithiasis       Date:  2016-07-08       Impact factor: 3.436

3.  Reactive oxygen species mediated calcium oxalate crystal-induced expression of MCP-1 in HK-2 cells.

Authors:  Pouran Habibzadegah-Tari; Karen G Byer; Saeed R Khan
Journal:  Urol Res       Date:  2006-01-06

4.  Antiurolithic effects of medicinal plants: results of in vivo studies in rat models of calcium oxalate nephrolithiasis-a systematic review.

Authors:  Aslam Khan; Samra Bashir; Saeed R Khan
Journal:  Urolithiasis       Date:  2021-01-23       Impact factor: 3.436

5.  Selective Rac1 inhibition protects renal tubular epithelial cells from oxalate-induced NADPH oxidase-mediated oxidative cell injury.

Authors:  Vijayalakshmi Thamilselvan; Mani Menon; Sivagnanam Thamilselvan
Journal:  Urol Res       Date:  2011-08-04

6.  Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease.

Authors:  Jacob A Torres; Mina Rezaei; Caroline Broderick; Louis Lin; Xiaofang Wang; Bernd Hoppe; Benjamin D Cowley; Vincenzo Savica; Vicente E Torres; Saeed Khan; Ross P Holmes; Michal Mrug; Thomas Weimbs
Journal:  J Clin Invest       Date:  2019-07-30       Impact factor: 14.808

7.  Hyperoxaluria-induced tubular ischemia: the effects of verapamil on the antioxidant capacity of the affected kidneys.

Authors:  Kemal Sarica; Alper Kafkasli; Fehmi Narter; Oguz Ozturk; Ozgur Yazici; Bilal Hamarat; Cahit Sahin; Bilal Eryildirim
Journal:  Urolithiasis       Date:  2016-06-09       Impact factor: 3.436

Review 8.  Hyperoxaluria-induced oxidative stress and antioxidants for renal protection.

Authors:  Saeed R Khan
Journal:  Urol Res       Date:  2005-11-15

9.  Taurine protected kidney from oxidative injury through mitochondrial-linked pathway in a rat model of nephrolithiasis.

Authors:  Cheng Yang Li; Yao Liang Deng; Bing Hua Sun
Journal:  Urol Res       Date:  2009-06-10

10.  Limitation of apoptotic changes in renal tubular cell injury induced by hyperoxaluria.

Authors:  Kemal Sarica; Ahmet Erbagci; Faruk Yağci; Kemal Bakir; Sakip Erturhan; Ramazan Uçak
Journal:  Urol Res       Date:  2004-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.